SAMYANG BIOPHARM CORPORATION · (주)삼양바이오팜
Last · KSE₩40600.00-2600.00 (-6.02%)close · yahoo · 8h ago
Market cap₩301.9B7.4M sh
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
₩23250.00₩150900.00
Volume33.5Ksession
| Revenue | ₩28.6B |
|---|---|
| Operating income | ₩2.7B |
| Net income | ₩2.2B |
| Free cash flow | ₩3.0B |
| Operating margin | 9.4% |
| Net margin | 7.8% |
| Return on equity | 1.0% |
| Period | 2025 |
Loading chart…
Documents
FormReporting forFiledFlags